Is VeriSign (VRSN) Undervalued Following Its Class Action Lawsuit?

A new class action targeting VeriSign (VRSN) has put the company’s .com pricing and registry contracts under scrutiny. The lawsuit challenges its relationship with ICANN and raises questions about potential antitrust and regulatory risks.

VeriSign’s share price has climbed 21.43% year to date to US$292.08, while the 1 year total shareholder return of 5.58% and 3 year total shareholder return of 43.97% suggest longer term holders have seen steadier gains, even as the latest lawsuit adds a fresh layer of perceived regulatory risk.

Spot potential alternatives to VeriSign’s regulated pricing model by scanning the 82 resilient stocks with low risk scores, which may offer steadier business profiles in the face of legal and policy shocks.

Bulls point to VeriSign’s high margins and long contracts. Bears focus on the lawsuit and concentrated .com reliance. The valuation section next asks which side current pricing and cash generation metrics lean toward.

Most Popular Narrative: 9.1% Undervalued

The most followed narrative on VeriSign values the stock at $321.40, which sits above the last close at $292.08 and frames today’s lawsuit headlines against a higher long term fair value anchor.

VeriSign's financial stability and strategic initiatives, including dividends, buybacks, and effective refinancing, position it for positive revenue growth and investor confidence.

Read the complete narrative.

Want to understand why this narrative still sees upside despite legal and regulatory overhangs? The key assumptions rest on steady domain growth, slightly rising margins, and a premium profit multiple usually reserved for high quality infrastructure companies. Curious how these moving parts add up to that fair value target.

Result: Fair Value of $321.40 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, this VeriSign narrative still hinges on smooth regulatory outcomes and steady domain trends, so setbacks on .com or .net contracts could quickly challenge those assumptions.

Find out about the key risks to this VeriSign narrative.

Another View on VeriSign: DCF Points to Overvaluation

The popular VeriSign narrative leans on analyst targets that imply 9.1% upside to $321.40. Our DCF model presents a different perspective. Using that framework, the stock at $292.08 sits above an estimated future cash flow value of $226.09, which suggests overvaluation rather than a discount.

If cash flows indicate less upside than the prevailing narrative, you may wish to consider which lens should carry more weight for you as an investor.

Look into how the SWS DCF model arrives at its fair value.

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out VeriSign for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 47 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

With VeriSign pulling investors in both directions on valuation and legal risk, move quickly to review the full picture and weigh the 2 key rewards and 3 important warning signs.

Looking for more ideas beyond VeriSign?

If you only focus on VeriSign you could miss other opportunities with different risk profiles. Use the Simply Wall St Screener to compare fresh ideas side by side.

• Target dependable cash generators and strong balance sheets by checking the list of solid balance sheet and fundamentals (52 results).
• Hunt for potential bargains with quality financials using the 47 high quality undervalued stocks.
• Build a steadier income stream by reviewing the 11 dividend fortresses.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com